These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5384122)

  • 61. Evolution of managed care pharmacy and therapeutics committees.
    Penna P
    Manag Care Interface; 2006 Jan; 19(1):40-1. PubMed ID: 16453994
    [No Abstract]   [Full Text] [Related]  

  • 62. [Drug committees should not recommend "off label" prescriptions].
    Rane A
    Lakartidningen; 2006 Apr 12-25; 103(15-16):1219. PubMed ID: 16696203
    [No Abstract]   [Full Text] [Related]  

  • 63. Adverse drug reactions and the P & T committee.
    Lipman AG
    Hosp Formul; 1980 Jul; 15(7):580. PubMed ID: 10247654
    [No Abstract]   [Full Text] [Related]  

  • 64. [Choice of drugs--by whom, for whom and to what costs?].
    Frisk M; Strömstedt A
    Lakartidningen; 2000 Sep; 97(39):4343-6. PubMed ID: 11076479
    [No Abstract]   [Full Text] [Related]  

  • 65. [Towards a new drug management].
    Hoffmann M; Ahlner J
    Lakartidningen; 1995 Oct; 92(41):3804, 3807. PubMed ID: 7564634
    [No Abstract]   [Full Text] [Related]  

  • 66. [Drug committees in hospital].
    Haug E
    Tidsskr Nor Laegeforen; 1970 Jan; 90(1):3-4. PubMed ID: 5426191
    [No Abstract]   [Full Text] [Related]  

  • 67. The critical path initiative: what is in it for P&T Committees?
    Hirschmann JL
    Manag Care Interface; 2006 Oct; 19(10):14. PubMed ID: 17117594
    [No Abstract]   [Full Text] [Related]  

  • 68. Promoting rational drug use through the ASHP Commission on Therapeutics.
    Witmer DR
    Am J Hosp Pharm; 1994 Jun; 51(12):1536. PubMed ID: 8092154
    [No Abstract]   [Full Text] [Related]  

  • 69. Most P&T committees influence hospital drug-prescribing patterns.
    Hosp Formul; 1977 Jul; 12(7):482. PubMed ID: 10305410
    [No Abstract]   [Full Text] [Related]  

  • 70. [Swedish drug information of international interest].
    Osterberg S
    Lakartidningen; 1975 Jun; 72(26):2743. PubMed ID: 1142909
    [No Abstract]   [Full Text] [Related]  

  • 71. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Drug supply report and expert pronouncement].
    Rosén A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469312
    [No Abstract]   [Full Text] [Related]  

  • 73. [Letter: The role of the National Board of Health and Welfare in drug information].
    Liljestrand A; Rosén A
    Lakartidningen; 1976; 73(20):1881-2. PubMed ID: 1271917
    [No Abstract]   [Full Text] [Related]  

  • 74. The Pharmacy and Therapeutics Committee Part 1: overview.
    Bender FH
    Hosp Formul; 1983 May; 18(5):517-8, 523-4, 533 passim. PubMed ID: 10260199
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Quality assurance of the basic list of drugs].
    Wallén L; von Bahr C
    Lakartidningen; 1996 Oct; 93(41):3550, 3552. PubMed ID: 8965505
    [No Abstract]   [Full Text] [Related]  

  • 76. [Modification of the prescribing practice of the physician by decisions of drug committees, specialty groups and consensus conferences].
    Müller-Oerlinghausen B
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):606-10. PubMed ID: 9527451
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The DERP: is it an effective methodology?
    Heaton AH
    Health Aff (Millwood); 2006; 25(4):W276-8. PubMed ID: 16757488
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Drug and therapeutics committees: the relationships among structure, function, and effectiveness.
    Plumridge RJ; Stoelwinder JU; Rucker TD
    Hosp Pharm; 1993 Jun; 28(6):492-3, 496-8, 508. PubMed ID: 10126453
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Evaluation of a therapeutics committee's work].
    Dolby J; Ekblom B; Elfvik P; Gunne LM; Jansson S; Kalling M; Nordlander NB; Skagerberg H; Anggård E
    Lakartidningen; 1974 Sep; 71(37):3355-6. PubMed ID: 4409501
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.